Camil Ciprian Mireștean (Ciprian Camil Mireștean, Camil Ciprian Mireştean)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 20

Top Topics

Cancer Stem Cells

Radiation Induced

Metastatic Breast Cancer

Top Venues

Diagnostics (Basel, Switzerland)

Journal of clinical medicine

Current oncology (Toronto, Ont.)

International journal of environmental research and public health

This page only lists publications with an associated author ORCID identifier.

Publications

Mihai Cosmin Stan, Daniel Georgescu, Camil Ciprian Mireștean, Florinel Bădulescu
Cancer and Diabetes: Predictive Factors in Patients with Metabolic Syndrome. Diagnostics (Basel, Switzerland) 13 (16) (2023)
Camil Ciprian Mireștean, Cristiana Eugenia Simionescu, Roxana Irina Iancu, Mihai Cosmin Stan, Dragoș Petru Teodor Iancu, Florinel Bădulescu
Head and Neck Low Grade Chondrosarcoma-A Rare Entity. Diagnostics (Basel, Switzerland) 13 (19) (2023)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics-An Urgent Alliance for the Front Line of the War against Head and Neck Cancers. Diagnostics (Basel, Switzerland) 13 (12) (2023)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept. Journal of clinical medicine 12 (6) (2023)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept. Journal of clinical medicine 12 (6) (2023)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Active Immune Phenotype in Head and Neck Cancer: Reevaluating the Iso-Effect Fractionation Based on the Linear Quadratic (LQ) Model-A Narrative Review. Current oncology (Toronto, Ont.) 30 (5) (2023)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Simultaneous Integrated Boost (SIB) vs. Sequential Boost in Head and Neck Cancer (HNC) Radiotherapy: A Radiomics-Based Decision Proof of Concept. Journal of clinical medicine 12 (6) (2023)
Camil Ciprian Mireștean, Mihai Cosmin Stan, Roxana Irina Iancu, Dragoș Petru Teodor Iancu, Florinel Bădulescu
The Prognostic Value of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)-A Retrospective Single Center Study and a Literature Review. Diagnostics (Basel, Switzerland) 13 (22) (2023)
Camil Ciprian Mireștean, Mihai Cosmin Stan, Michael Schenker, Constantin Volovaț, Simona Ruxandra Volovăț, Dragoș Teodor Petru Iancu, Roxana Irina Iancu, Florinel Bădulescu
Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers-Early Experiences from Romania and Literature Review. Diagnostics (Basel, Switzerland) 13 (16) (2023)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Image Guided Radiotherapy (IGRT) and Delta (Δ) Radiomics-An Urgent Alliance for the Front Line of the War against Head and Neck Cancers. Diagnostics (Basel, Switzerland) 13 (12) (2023)
Camil Ciprian Mireștean, Constantin Volovăț, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease. Journal of clinical medicine 11 (3) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Capecitabine-A "Permanent Mission" in Head and Neck Cancers "War Council"? Journal of clinical medicine 11 (19) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
p53 Modulates Radiosensitivity in Head and Neck Cancers-From Classic to Future Horizons. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Micro-RNAs, the Cornerstones of the Future of Radiobiology in Head and Neck Cancers? Current oncology (Toronto, Ont.) 29 (2) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Teodor Iancu
Immunotherapy and Radiotherapy as an Antitumoral Long-Range Weapon-A Partnership with Unsolved Challenges: Dose, Fractionation, Volumes, Therapeutic Sequence. Current oncology (Toronto, Ont.) 29 (10) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
Education in Radiation Oncology-Current Challenges and Difficulties. International journal of environmental research and public health 19 (7) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
p53 Modulates Radiosensitivity in Head and Neck Cancers-From Classic to Future Horizons. Diagnostics (Basel, Switzerland) 12 (12) (2022)
Camil Ciprian Mireștean, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
An Underestimated Toxicity Radiation-Induced Hypothyroidism in Patients Multimodally Treated for Breast Cancer. Journal of clinical medicine 10 (23) (2021)
Camil Ciprian Mireștean, Anda Crișan, Adina Mitrea, Călin Buzea, Roxana Irina Iancu, Dragoș Petru Teodor Iancu
New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era. Journal of clinical medicine 10 (4) (2021)
Camil Ciprian Mireștean, Anda Crişan, Călin Buzea, Roxana Irina Iancu, DragoşPetru Teodor Iancu
Synergies Radiotherapy-Immunotherapy in Head and Neck Cancers. A New Concept for Radiotherapy Target Volumes-"Immunological Dose Painting". Medicina (Kaunas, Lithuania) 57 (1) (2020)